In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Heritage Clarifies No Guilty Plea In US Settlement

Executive Summary

Heritage has clarified that its recent settlement deal with the US Department of Justice over price-fixing allegations did not include the company entering a guilty plea.

You may also be interested in...



Emcure Aims To Split Itself In Half

By the middle of next year, Emcure intends to have demerged its operations in highly developed markets from its activities in India and other emerging markets. The Indian group is seeking private-equity support to grow inorganically in North America and Europe.

Insurance Giant Sues Again On US Pricing

Mylan, Sandoz and Teva, as well as Apotex, Aurobindo, Dr Reddy’s and Lupin, are among the companies accused of price-fixing in the US in an action brought by US insurance giant Humana.

Bernie Sanders Urges DoJ To Take Action On Price-Fixing Claims

Bernie Sanders and Elijah Cummings have written to the DoJ urging strict action against all generic drug manufacturing companies accused of a price-fixing conspiracy.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

LL043097

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel